Nā ʻano hana
Ka palena ʻike: 1.0 ng/ mL;
Laina Linear: 1.0-1000.0ng / mL;
Koefficient huikau laina R ≥ 0.990;
Ka pololei: i loko o ka puʻupuʻu CV ʻo ≤ 15%;ma waena o nā pūʻulu CV he ≤ 20%;
Pono: ʻaʻole ʻoi aku ka ʻae ʻana o nā hopena ana ma mua o ± 15% ke hoʻāʻo ʻia ka calibrator pololei i hoʻomākaukau ʻia e Ferritin national standard a i ʻole standardized accuracy calibrator.
1. E mālama i ka mea ʻike maka ma 2~30 ℃.Kūpaʻa ka buffer a hiki i 18 mahina.
2. E kūʻai i ka cassette hōʻike Aehealth Ferritin Rapid Quantitative ma 2~30 ℃, a hiki i ka 18 mahina.
3. Pono e hoʻohana i ka pahu hoʻāʻo i loko o 1 hola ma hope o ka wehe ʻana i ka ʻeke.
ʻO ka maʻi maʻi Hepatitis C (HCV) he envelope, hoʻokahi stranded positive sense RNA (9.5 kb) virus no ka ʻohana Flaviviridae.Ua ʻike ʻia nā ʻano genotype ʻeono a me nā ʻano subtypes o HCV.Hoʻokaʻawale ʻia i ka makahiki 1989, ʻike ʻia ʻo HCV ʻo ke kumu nui o ka hoʻopā ʻana i pili i ka maʻi hepatitis non-A, non-B.Hōʻike ʻia ka maʻi me ke ʻano acute a me ka maʻi.ʻOi aku ma mua o 50% o ka poʻe i loaʻa i ka maʻi i hoʻomohala ʻia i ka maʻi hepatitis maʻi hoʻoweliweli me ka cirrhosis ate a me nā maʻi hepatocellular carcinomas.Mai ka hoʻomaka ʻana i ka makahiki 1990 o ka hōʻike ʻana i ka anti-HCV o nā hāʻawi koko, ua hoʻemi nui ʻia ka nui o kēia maʻi i ka poʻe lawe paʻi.Hōʻike nā haʻawina lāʻau lapaʻau i ka nui o ka poʻe i loaʻa i ka maʻi HCV e hoʻomohala i nā antibodies i ka NS5 non-structural protein o ka maʻi.No kēia, ua komo nā hoʻāʻo i nā antigens mai ka ʻāina NS5 o ka genome viral me ka NS3 (c200), NS4 (c200) a me ka Core (c22).